Western Health Advantage
Xtandi (enzalutamide)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: 30 day supply per 1 fill(s).
  • Metastatic Prostate Cancer:
    Duration: 6 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Non-Metastatic Prostate Cancer:
    Duration: 6 Month(s)
    Gender Requirement: Male
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

  • Available through Specialty Pharmacy;
  • PA Required
  • Prior Authorization: Metastatic Prostate Cancer:
    Documented Diagnosis: Yes
    Duration: 6 Month(s)

    Non-Metastatic Prostate Cancer:
    Documented Diagnosis: Yes
    Gender Requirement: Male
    Duration: 6 Month(s)